Vertex was one of the few to trudge ahead ... as a treatment for the sharp, short-lived “acute” pain usually felt after an accident or a surgery. Expectations around Journavx are high.
Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback